| Neck Carcinoma studied in …STUDIED_INderived200 of 1,419show all (up to 200) |
|---|
| → studied in | NCT02465060Phase 2 · active not recruiting Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) · condition mapped CURATED_BROADER · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04085900recruiting Screening Nasopharyngeal Carcinoma With EBV Associated Biomarkers in Zhongshan City · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06479811Phase 1 · recruiting [212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06589804Phase 3 · recruiting Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment · condition mapped CURATED_BROADER · 1,419 trials mapped (591 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07667400Phase 1/Phase 2 · not yet recruiting Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04216732recruiting Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management · condition mapped CURATED_BROADER · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05136196Phase 2 · recruiting BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study · condition mapped CURATED_BROADER · 1,419 trials mapped (591 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06980038Phase 2 · recruiting Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07124000recruiting DESTINY-PANTUMOUR04 · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Throat Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07142005recruiting Cultural Adaptation of an Educational Tool in Medullary Thyroid Cancer · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02293954NA · active not recruiting Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05575440terminated Evaluation of 18F-TFB PET/CT Scan in Patients With Differentiated Thyroid Cancer · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Differentiated Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06475989Phase 3 · recruiting Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer · condition mapped CURATED_BROADER · 1,419 trials mapped (591 active) | — | — | Differentiated Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05290194Phase 2 · withdrawn Radiotherapy Combined With PD-1 Monoclonal Antibody and Capecitabine in the Treatment of Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05814549active not recruiting A Study Using Human Papillomavirus (HPV) DNA Testing to Detect HPV-Related Oropharyngeal Cancer (OPC) · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01660984active not recruiting Natural History Study of Children and Adults With Medullary Thyroid Cancer · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04522570NA · completed Thermal Ablation of Cervical Metastases From Thyroid Carcinoma · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Differentiated Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04671667Phase 2 · recruiting Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 1,419 trials mapped (591 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05172245Phase 1 · recruiting Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer · condition mapped CURATED_BROADER · 1,419 trials mapped (591 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06814496Phase 1/Phase 2 · recruiting Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07006727Phase 1 · recruiting Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07060261NA · recruiting Pre-Op MRI on Margin Status for Transoral Robotic Surgery for HPV+ Tonsillar Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Tonsillar Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07565740Phase 1 · recruiting Intranasal WSK-IM05 Vaccine Plus Tislelizumab as Neoadjuvant Therapy for HPV+ OPSCC · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05172258Phase 2 · active not recruiting Testing the Addition of an Anti-cancer Drug, Ipatasertib, to the Usual Immunotherapy Treatment (Pembrolizumab) in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck · condition mapped CURATED_BROADER · 1,419 trials mapped (591 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05904080Phase 2 · suspended Testing Nivolumab and Ipilimumab Immunotherapy With or Without the Targeted Drug Cabozantinib in Recurrent, Metastatic, or Incurable Nasopharyngeal Cancer · condition mapped CURATED_BROADER · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04544111Phase 2 · active not recruiting PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Follicular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06629597Phase 3 · active not recruiting A Phase III Study of YL201 in Recurrent or Metastatic Nasopharyngeal Carcinoma (TAISHAN-301) · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07177443Phase 3 · recruiting Serplulimab Combined With Induction Chemotherapy and Radiotherapy in Nasopharyngeal Carcinoma · condition mapped CURATED_BROADER · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07824856Phase 2 · not yet recruiting Local Ablation Plus Systemic Therapy for Metachronous Liver and/or Lung Oligometastases From Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04467021NA · active not recruiting Cancer and Blood Pressure Management, CARISMA Study · condition mapped CURATED_BROADER · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05786924Phase 1/Phase 2 · recruiting Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06029270Phase 2 · recruiting Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer · condition mapped CURATED_BROADER · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06235216Phase 2 · recruiting Sacituzumab govitEcan in THYroid Cancers · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07140757recruiting Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07797881Phase 2 · not yet recruiting A Study of BL-B01D1 With or Without PD-1 Monoclonal Antibody in Patients With High-Risk Locally Advanced Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07823439not yet recruiting Pattern and Surgical Outcome of Papillary Thyroid Cancer at Sohag University Hospitals · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05880797recruiting Multidimensional and Multimodal Profiling of Oropharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Oropharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07783321Phase 3 · not yet recruiting A Study of Anti-PD-1 Antibody With or Without BL-B01D1 as Maintenance Therapy Following Anti-PD-1 Antibody Plus Chemotherapy for the First-line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma (PANKU-NPC02) · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07819656recruiting Dynamic Risk Prediction of Severe Myelosuppression in Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02734537Phase 2 · recruiting Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03074513Phase 2 · active not recruiting Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors · condition mapped CURATED_BROADER · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04255849Phase 3 · active not recruiting Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05721755Phase 3 · active not recruiting Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and Neck · condition mapped CURATED_BROADER · 1,419 trials mapped (591 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05752149Phase 2 · recruiting Fluorescence-guided Surgery in Laryngeal- and Hypopharyngeal Cancer: a Feasibility Trial · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Laryngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06064097Phase 2 · recruiting A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC) · condition mapped CURATED_BROADER · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07513389Phase 2 · recruiting Omission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION) · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07818486Phase 1/Phase 2 · not yet recruiting A Study of BL-M08D1 in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma and Other Solid Tumors · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06055868active not recruiting People Living With HIV, Oral and Oropharyngeal Cancer, and Health Equity · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07181720Phase 1 · suspended CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07218315NA · recruiting Nanosecond Pulsed Field Ablation in the Management of T1N0M0 Papillary Thyroid Carcinoma · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02135042Phase 2/Phase 3 · active not recruiting Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA · condition mapped CURATED_BROADER · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03647358Phase 1 · recruiting Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05557045Phase 1 · active not recruiting A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815 · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07513324Phase 2 · not yet recruiting Risk-adapted Therapy in HPV-positive Oropharyngeal Cancer Using Circulating Tumor (ct) HPV DNA Profiling (ReACT 2.0) · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07812467Phase 2 · not yet recruiting Rimegepant-Sensitized Neoadjuvant Chemoimmunotherapy for Oral or Oropharyngeal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07812779not yet recruiting Thyroid Health Outcomes Registry for Surgery · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06902376Phase 1 · recruiting XL092 and Cemiplimab in BRAF WT Thyroid Cancer · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07156227Phase 1 · recruiting Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 1,419 trials mapped (591 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05334069recruiting Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06761937Phase 1 · active not recruiting Thermotherapy for Locally Advanced Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Oropharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06763289active not recruiting Comparison of Multi-omics Models for Early Nasopharyngeal Carcinoma Screening: cfDNA Methylation, EBV DNA, and Serological Double-antibodies Detection · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06790966Phase 3 · terminated Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07485569Phase 1 · active not recruiting Drug Repurposing in Thyroid Carcinoma: a Feasibility Trial · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07625423Phase 1 · recruiting Intratumoral Injection of Recombinant Human Endostatin Adenovirus (EDS01) for the Treatment of Recurrent or Metastatic Head and Neck Tumors · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07690618Phase 1 · recruiting Thermotherapy for Head and Neck Cancer Patients · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Oropharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01810913Phase 2/Phase 3 · suspended Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06787456recruiting "Xijiang Project" Screening Cohort for NPC · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07796789Phase 3 · recruiting Prophylactic Nanocrystalline Megestrol Acetate Versus Placebo for Chemoradiotherapy-Related Anorexia in Nasopharyngeal Carcinoma · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07797738NA · not yet recruiting Prognostic Biomarkers for Patients With Human Papillomavirus (HPV) Positive Oropharyngeal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00001160recruiting Studies on Tumors of the Thyroid · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Oncocytic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05126719Phase 2 · active not recruiting A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With Recurrent Metastatic Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06976190Phase 3 · recruiting A Study of MRG003 in Combination With Pucotenlimab Versus Chemotherapy in the Treatment of Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07768189Phase 3 · not yet recruiting A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Oropharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07794488Phase 2 · not yet recruiting Platinum-Free Regimen in Nasopharyngeal Carcinoma · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00588770Phase 3 · active not recruiting Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 1,419 trials mapped (591 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02152995Phase 2 · active not recruiting Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer · condition mapped CURATED_BROADER · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02867592Phase 2 · active not recruiting Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors · condition mapped CURATED_BROADER · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03258554Phase 2/Phase 3 · completed Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04943445Phase 2 · completed Study of a Pembrolizumab-based Organ Preservation Strategy for Locally Advanced Larynx Cancers · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Laryngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07058805Phase 2 · recruiting Compartmentalized Postoperative Radiotherapy in Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07137052recruiting Precise Guidance of Adaptive Radiotherapy for Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07201337Phase 3 · active not recruiting Reduced-dose vs Standard-dose Irradiation for Low-risk Clinical Target Volume in Nasopharyngeal Carcinoma. · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07789158Phase 2 · not yet recruiting Induction Chemotherapy Response-Guided Reduced-Dose Radiotherapy for Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04456322Phase 3 · active not recruiting Radiotherapy Plus Nimotuzumab or Cisplatin in Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06016920Phase 1/Phase 2 · recruiting Safety and Efficacy of VB10.16 and Pembrolizumab in Patients With Head-Neck Squamous Cell Carcinoma · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07392580Phase 2 · recruiting Intralesional Chemotherapy (IC): Cisplatin + Epinephrine · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Laryngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02568267Phase 2 · active not recruiting Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07784855NA · not yet recruiting Scheduled IV Fluids in the Supportive Management of Patients Undergoing Chemo-radiotherapy for Head and Neck Cancer · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04910347Phase 2 · active not recruiting Consolidation Nivolumab After Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma · condition mapped CURATED_BROADER · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07781358Phase 2 · recruiting Becotatug Vedotin Combined With a PD-1 Inhibitor in the Treatment of Locally Advanced Recurrent Nasopharyngeal Carcinoma. · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01893307Phase 3 · active not recruiting Intensity-Modulated Proton Beam Therapy or Intensity-Modulated Photon Therapy in Treating Patients With Stage III-IVB Oropharyngeal Cancer · condition mapped CURATED_BROADER · 1,419 trials mapped (591 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04576091Phase 1 · active not recruiting Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer · condition mapped CURATED_BROADER · 1,419 trials mapped (591 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05245682early Phase 1 · active not recruiting Tolinapant and Radiation for Cisplatin-Ineligible, Previously Untreated, Locally Advanced Head and Neck Cancer · condition mapped CURATED_BROADER · 1,419 trials mapped (591 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07636499Phase 1 · active not recruiting Selective Neck Dissection Under Multimodal Assessment for N3 Nasopharyngeal Carcinoma After Radiotherapy · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00336063Phase 1 · active not recruiting Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell Lymphoma · condition mapped CURATED_BROADER · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Keratinizing Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06931743NA · recruiting The Application of Electrical Stimulation in Postoperative Pain Management of Thyroid Surgery · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06532279Phase 2 · recruiting Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07440290Phase 2/Phase 3 · recruiting DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers. · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07441681Phase 3 · recruiting Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin · condition mapped CURATED_BROADER · 1,419 trials mapped (591 active) | — | — | Hypopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04920344Phase 2 · active not recruiting Swallowing Outcomes and Circulating Tumor DNA in Patients With HPV Related Oropharyngeal Cancer Treated With Transoral Surgery and Reduced Intensity Adjuvant Therapy · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05453799Phase 2 · suspended Vudalimab for the Treatment of Locally Advanced or Metastatic Anaplastic Thyroid Cancer or Hurthle Cell Thyroid Cancer · condition mapped CURATED_BROADER · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07418034Phase 2 · not yet recruiting A Single Arm Phase II Trial in p16-positive Oropharynx Cancer of Selective Dose De-escalation of nodAl VolumEs at Minimal Risk and Primary Site Disease (SAVED) · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Oropharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07764887NA · not yet recruiting Impacted Tooth Management and Osteoradionecrosis Risk in NPC · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06712888Phase 3 · active not recruiting Toripalimab vs. Placebo Wtih GP Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07762976Phase 2 · recruiting Dynamic Risk-adapted EBV-DNA and MRI-guided De-concurrent Chemotherapy in Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04609280Phase 2 · active not recruiting Selective Avoidance of Nodal VolumEs at Minimal Risk (GCC 20110) · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05979961Phase 3 · active not recruiting Phase III Trial of Concurrent Chemotherapy Alone in Patients With Low-risk Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04675710Phase 2 · active not recruiting Pembrolizumab, Dabrafenib, and Trametinib Before Surgery for the Treatment of BRAF-Mutated Anaplastic Thyroid Cancer · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05119036NA · completed Adjuvant Treatment Deintensification After Transoral Surgery for Human Papillomavirus-Positive Squamous Cell Carcinoma · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05591092terminated Radioiodine Planar and a SPECT/CT Imaging With Iodine-123 for Evaluation of Follicular Thyroid Nodules Prior to Surgery · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Follicular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06915038NA · recruiting ctHPVDNA in HPV Positive Squamous Cell Carcinoma of the Oropharynx · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07650266Phase 1 · not yet recruiting A Study of Cemiplimab and Fianlimab in People With Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07652450NA · completed Incidental Thyroid Cancer in Cases With Inflammatory Thyroid Lesion · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04171622Phase 2 · active not recruiting Lenvatinib and Pembrolizumab for the Treatment of Stage IVB Locally Advanced and Unresectable or Stage IVC Metastatic Anaplastic Thyroid Cancer · condition mapped CURATED_BROADER · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04623801Phase 2 · active not recruiting Laser Ablation of Papillary Thyroid Microcarcinoma · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Papillary Microcarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07756190Phase 2 · not yet recruiting Radscopal Radiotherapy Plus Immunotherapy for Chemotherapy-Ineligible Patients With Newly Diagnosed Metastatic Nasopharyngeal Cancer: A Single-Center, Open-Label, Phase II Study · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04280081Phase 2 · active not recruiting A Study of Selpercatinib (LY3527723) in Participants With Advanced Solid Tumors Including RET Fusion-positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET Activation · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04502407Phase 2 · active not recruiting Trial of De-Intensified Post-operative Chemoradiation Following Robotic Surgery for HPV-positive Oropharyngeal Cancer · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04900623Phase 2 · recruiting Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06115772recruiting Prospective Assessment of HPV Associated Anogenital Pathology in Female Patients and Female Partners of Patients With Confirmed HPV Associated Oropharyngeal Carcinoma, PAP-OP Study · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07713901enrolling by invitation Database Linkage Study to Evaluate the Risk of Medullary Thyroid Carcinoma · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03803774Phase 1 · active not recruiting Birinapant and Intensity Modulated Re-Irradiation Therapy in Treating Patients With Locally Recurrent Head and Neck Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07741110completed Biomarker Analysis Data From a Randomized Phase II Study in Patients With Nasopharyngeal Carcinoma Treated With Chemotherapy and Radiotherapy · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02567422Phase 1 · active not recruiting Testing the Addition of M6620 (VX-970, Berzosertib) to Usual Chemotherapy and Radiation for Head and Neck Cancer · condition mapped CURATED_BROADER · 1,419 trials mapped (591 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03914300Phase 2 · active not recruiting Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Differentiated Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05063552Phase 2/Phase 3 · active not recruiting Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers · condition mapped CURATED_BROADER · 1,419 trials mapped (591 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06947668recruiting Immune Biomarker Study for Cisplatin-ineligible Patients Receiving Chemoradiotherapy With Docetaxel · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07259304active not recruiting Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors · condition mapped CURATED_BROADER · 1,419 trials mapped (591 active) | — | — | Differentiated Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07172256Phase 2 · recruiting CUE-101with Pembrolizumab for Locally Advanced HPV+HNSCCs · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06854510Phase 2/Phase 3 · active not recruiting Sodium Bicarbonate for Reducing Radiation-Induced Oral Mucositis in Nasopharyngeal Carcinoma. · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07470489Phase 2 · not yet recruiting Zanzalintinib Plus Cemiplimab for the Treatment of BRAF Wild-Type Anaplastic Thyroid Cancer · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03181100Phase 2 · active not recruiting Atezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly Differentiated Thyroid Cancer · condition mapped CURATED_BROADER · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04754321Phase 1 · recruiting Combining Immunotherapy Salvage Surgery & IORT Tx Persistent/Recurrent Head & Neck Cancer · condition mapped CURATED_BROADER · 1,419 trials mapped (591 active) | — | — | Laryngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06475300Phase 2 · recruiting A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07528183Phase 2 · recruiting Maintenance Immunotherapy With Deferred Salvage Radiotherapy After Response to Chemoimmunotherapy in Recurrent Nasopharyngeal Carcinoma · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04877613Phase 1 · active not recruiting GFRα4 CAR T Cells in MTC Patients · condition mapped CURATED_BROADER · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05419089Phase 2 · recruiting The Sinai Robotic Surgery Trial in HPV-related Oropharyngeal Squamous Cell Carcinoma (SIRS 2.0 Trial) · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07718620NA · recruiting HPV-associated Oropharyngeal Carcinoma (HPV-OPC) · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Oropharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07241273NA · not yet recruiting SPECT-CT Guided ELEctive Contralateral Neck Treatment in Lateralized Oropharyngeal Cancer · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04852328Phase 2 · recruiting Three Schedules of CUE-101 Administered Before Surgery or Definitive Chemoradiation Therapy in HLA-A*0201 Positive Patients With Locally Advanced, HPV16-Positive Oropharyngeal Squamous-Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03892993NA · recruiting Patient Decision Aid in Supporting Decision-Making About When to Start or Stop New Drugs, Join Clinical Trials, or Continue Active Surveillance in Patients With Medullary Thyroid Cancer and Their Caregivers · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04874493active not recruiting Patient Reported Outcome Post Radiation Therapy or Chemoradiotherapy Patient Care in Patients With Oropharyngeal Cancer · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Oropharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05075980Phase 2 · active not recruiting Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Hypopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06662058NA · recruiting Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07064902Phase 2 · not yet recruiting Ivonescimab Combined With Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07665190Phase 2 · recruiting Neoadjuvant EGFR-ADC Combined With Anti-PD-1 Monoclonal Antibody in Resectable Locally Advanced Hypopharyngeal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07706985Phase 3 · recruiting Efficacy and Safety of TPC Induction Chemotherapy Combined With Nimotuzumab and Toripalimab "Immune Sandwich" Regimen Versus Full-Course Immunotherapy for Locally Advanced Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01365169NA · recruiting Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients" · condition mapped CURATED_BROADER · 1,419 trials mapped (591 active) | — | — | Hypopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04284774Phase 2 · active not recruiting Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial · condition mapped CURATED_BROADER · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05799144Phase 2 · recruiting pBI-11 & TA-HPV (With Pembrolizumab as Treatment for Patients w/Advanced, PD-L1 CPS≥1, hrHPV+ Oropharyngeal Cancer · condition mapped CURATED_BROADER · 1,419 trials mapped (591 active) | — | — | Oropharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07521670Phase 2 · not yet recruiting Sacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP) · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07705243Phase 3 · recruiting Efficacy and Safety of Becotatug Vedotin (MRG003) Combined With Anti-PD1 as Maintenance Therapy for Recurrent and Metastatic Nasopharyngeal Carcinoma · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07302672NA · recruiting Humanistic Continuing Care Via WeChat for Patients Undergoing Thermal Ablation of Papillary Thyroid Carcinoma · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04858269Phase 2 · active not recruiting First Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05813626Phase 2 · active not recruiting Neoadjuvant Chemotherapy Plus Toripalimab in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07695974completed Clinicopathological Predictors of Recurrence in Papillary Thyroid Carcinoma · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07692906NA · not yet recruiting Multimodal Evaluation-Guided Surveillance-Intervention With Endoscopic Selective Neck Dissection for Post-Radiotherapy N3 Nasopharyngeal Carcinoma · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06797986Phase 1/Phase 2 · recruiting A Phase I/IIa Clinical Trial to Investigate BVAC-E6E7 in Subjects With HPV Positive HNSCC. · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07545837NA · recruiting Health and Wellness Coaching to Improve Adherence to Healthy Habits and Treatment Plans in Papillary and Follicular Thyroid Cancer Survivors · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Follicular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07578467Phase 1/Phase 2 · not yet recruiting Combining Neo-adjuvant ATR-inhibition With Nodal SBRT for Early-stage Resectable HPV+ OPSCCs · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07578727NA · not yet recruiting A Multicenter, Prospective, Phase III Clinical Study of Proton Intensity-modulated Radiotherapy Versus Photon Intensity-modulated Radiotherapy for Untreated Non-metastatic Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03085056early Phase 1 · active not recruiting Trametinib in Combination With Paclitaxel in the Treatment of Anaplastic Thyroid Cancer · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05751486Phase 1 · completed A Clinical Study to Evaluate the Safety and Tolerability of JS001sc in Advanced Nasopharyngeal Carcinoma · condition mapped CURATED_BROADER · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06788002Phase 2 · recruiting LDRT and Chemoimmunotherapy in NPC With Liver Metastasis · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07686575recruiting Objective Response Rate of Ivonescimab With Chemotherapy in Locally Advanced Resectable Oral and Oropharyngeal Squamous Cell Carcinoma · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04238624Phase 2 · active not recruiting Study of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid Cancer · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01813136Phase 2 · completed Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03952585Phase 2/Phase 3 · active not recruiting De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05522881recruiting The Registry Study of Genetic Alterations of Oropharyngeal Cancer in Taiwan · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07118176Phase 1 · active not recruiting Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01772706NA · completed Laser Mucite ORL : Effectiveness of Laser Therapy for Mucositis Induced by a Radio-chemotherapy in Head and Neck Cancer · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02185560active not recruiting Prospective, Non-interventional, Post-authorization Safety Study That Includes All Patients Diagnosed as Unresectable Differentiated Thyroid Carcinoma and Treated With Sorafenib · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07674706NA · not yet recruiting Evaluating the Optimal Timing of Acupuncture for Managing Chemoradiation-induced Xerostomia in Patients With Head and Neck Cancers · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02856347NA · completed Prospective Study Evaluating the Medullary Thyroid Cancer Management's Care Using PET F-DOPA in Patients With a High Level of Postoperative Residual Thyrocalcitonin · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04151082Phase 1/Phase 2 · recruiting High Dose Steroid Therapy (Prednisone or Methylprednisolone) for the Improvement of Symptoms of Late Radiation-Associated Lower Cranial Neuropathy in Oropharyngeal Cancer Survivors · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Oropharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06959641Phase 2 · recruiting XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer · condition mapped CURATED_BROADER · 1,419 trials mapped (591 active) | — | — | Differentiated Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04862650Phase 2 · active not recruiting Cemiplimab, Low-Dose Paclitaxel and Carboplatin for the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck · condition mapped CURATED_BROADER · 1,419 trials mapped (591 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05050162Phase 2/Phase 3 · suspended Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer · condition mapped CURATED_BROADER · 1,419 trials mapped (591 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06790706Phase 2 · active not recruiting IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE Cancers · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04528394Phase 2 · completed Proton Versus Photon Radiotherapy for Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07529080NA · not yet recruiting Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA Trial · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Differentiated Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07659717completed Frozen Section-Guided Selective Ipsilateral Central Neck Dissection in Bethesda V-VI Thyroid Nodules · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05996523Phase 2 · active not recruiting Phase II Trial of Immunotherapeutic HPV Vaccine PRGN-2009 With Pembrolizumab Before Standard Treatment in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal Cancer · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06592599Phase 2 · recruiting Gemcitabine + Docetaxel + Toripalimab Induction in Epstein-Barr Virus (EBV) Associated Nasopharyngeal Carcinoma(NPC) · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03097939Phase 2 · active not recruiting Phase 2 Trial of Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07661420Phase 1 · not yet recruiting 211At-MABG in Adults With Advanced Neuroendocrine Cancers · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04965792active not recruiting Post-treatment Surveillance in HPV+ Oropharyngeal SCC · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04533750Phase 1 · active not recruiting Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin · condition mapped CURATED_BROADER · 1,419 trials mapped (591 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06682442NA · recruiting Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00494182Phase 2 · active not recruiting Sorafenib in Combination With Carboplatin and Paclitaxel in Treating Participants With Metastatic or Recurrent Head and Neck Squamous Cell Cancer · condition mapped CURATED_BROADER · 1,419 trials mapped (591 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05639972Phase 1/Phase 2 · recruiting E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05686226Phase 2 · recruiting E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Throat Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07303283Phase 2 · not yet recruiting Becotatug Vedotin as Adjuvant Therapy For High-risk Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07506161completed Radiofrequency Ablation Treatment of Low-Risk Papillary Thyroid Carcinomas · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Papillary Microcarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06287034recruiting The Role of the Free/Pedunculated Flap in Total Laryngectomy After (Chemo-)Radiotherapy Failure for Laryngeal Carcinoma: Impact on the Risk of Pharyngocutaneous Fistula (PCF) · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Laryngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06821243recruiting Patients With Human Papillomavirus-associated Head and Neck Cancer for the Discovery of Predictive Biomarkers to Guide Clinical Intervention · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07630363Phase 1/Phase 2 · not yet recruiting PTC-Guided Atorvastatin Plus Axitinib and Toripalimab in Advanced RCC · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07590024Phase 3 · recruiting RAIRI Model-Guided Adjuvant Therapy in Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,419 trials mapped (591 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07628062Phase 2 · not yet recruiting Phase 2 Study of NAI, HPV Vaccine, and Nab-Paclitaxel in HPV-Positive Oropharyngeal Cancer Followed by De-Intensified Radiation Compared With Standard Chemoradiation · condition mapped ALIAS · 1,419 trials mapped (591 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |